Clincosm LogoSign in Get a demo

clear cell renal cell carcinoma

Showing NaN - NaN of 16
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Clear Cell Renal Cell Carcinoma, Metastatic Malignant Tumor in the Bone, Metastatic Malignant Tumor in the Lymph Nodes Trial in

Recruiting
  • Clear Cell Renal Cell Carcinoma
  • +6 more
  • Anchorage, Alaska
  • +828 more
Feb 2, 2023

Clear Cell Renal Cell Carcinoma Trial in Worldwide (Belzutifan, Pembrolizumab, Placebo)

Recruiting
  • Clear Cell Renal Cell Carcinoma
  • Duarte, California
  • +250 more
Jan 27, 2023

Clear Cell Renal Cell Carcinoma Trial in United States (Batiraxcept, Cabozantinib (Cabo), Nivolumab)

Active, not recruiting
  • Clear Cell Renal Cell Carcinoma
  • Baltimore, Maryland
  • +16 more
Jan 17, 2023

Clear Cell Renal Cell Carcinoma, Metastatic Kidney Carcinoma, Stage III Renal Cell Cancer AJCC v7 Trial in United States

Active, not recruiting
Has Results
  • Clear Cell Renal Cell Carcinoma
  • +3 more
  • Aldesleukin
  • +6 more
  • Los Angeles, California
  • +3 more
Nov 16, 2022

ccRCC, RCC, Kidney Cancer Trial in United States (MK-3795, Nivolumab, Cabozantinib)

Active, not recruiting
  • ccRCC
  • +4 more
  • Los Angeles, California
  • +24 more
Jul 18, 2022

Clear Cell Renal Cell Carcinoma, Stage I Renal Cell Cancer AJCC v6 and v7, Stage II Renal Cell Cancer AJCC v7 Trial in Canada,

Completed
Has Results
  • Clear Cell Renal Cell Carcinoma
  • +3 more
  • Laboratory Biomarker Analysis
  • +4 more
  • Birmingham, Alabama
  • +986 more
Jan 13, 2022

Clear Cell Renal Cell Carcinoma Trial in United States (Placebo, CB-839, everolimus)

Completed
  • Clear Cell Renal Cell Carcinoma
  • Placebo
  • +2 more
  • Tucson, Arizona
  • +37 more
Aug 16, 2021

Clear Cell Renal Cell Carcinoma Trial in Worldwide (89Zr-girentuximab)

Recruiting
  • Clear Cell Renal Cell Carcinoma
  • 89Zr-girentuximab
  • Duarte, California
  • +29 more
Aug 4, 2021

Clear Cell Renal Cell Carcinoma, Metastatic Kidney Carcinoma, Stage III Renal Cell Cancer AJCC v7 Trial in United States

Completed
Has Results
  • Clear Cell Renal Cell Carcinoma
  • +3 more
  • Cabozantinib S-malate
  • +2 more
  • Mobile, Alabama
  • +487 more
Jan 28, 2021

Clear Cell Renal Cell Carcinoma Trial in Baltimore (Nivolumab)

Completed
  • Clear Cell Renal Cell Carcinoma
  • Baltimore, Maryland
    The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Jun 10, 2020

Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v7 Trial in United States

Terminated
Has Results
  • Clear Cell Renal Cell Carcinoma
  • +3 more
  • Bevacizumab
  • +3 more
  • Scottsdale, Arizona
  • +523 more
Mar 5, 2019

Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Carcinoma, Stage IV Renal Cell Cancer AJCC v7 Trial in Peru, United States

Completed
Has Results
  • Clear Cell Renal Cell Carcinoma
  • +2 more
  • Bevacizumab
  • +4 more
  • Birmingham, Alabama
  • +558 more
Oct 15, 2018

Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Carcinoma, Stage IV Renal Cell Cancer Trial in Australia, Taiwan, United

Completed
Has Results
  • Clear Cell Renal Cell Carcinoma
  • +4 more
  • Anti-Endoglin Chimeric Monoclonal Antibody TRC105
  • +3 more
  • Duarte, California
  • +29 more
Jul 30, 2018

Childhood Renal Cell Carcinoma, Clear Cell Renal Cell Carcinoma, Clear Cell Sarcoma of the Kidney Trial in Worldwide (drug,

Completed
Has Results
  • Childhood Renal Cell Carcinoma
  • +12 more
  • Doxorubicin Hydrochloride
  • +9 more
  • Birmingham, Alabama
  • +186 more
Jun 22, 2017

Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage III Renal Cell Cancer Trial in Baltimore, Salisbury, Madison

Completed
Has Results
  • Clear Cell Renal Cell Carcinoma
  • +3 more
  • Baltimore, Maryland
  • +2 more
Dec 10, 2015

Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage I Renal Cell Cancer Trial in Baltimore, Madison (drug,

Completed
  • Clear Cell Renal Cell Carcinoma
  • +6 more
  • sunitinib malate
  • +6 more
  • Baltimore, Maryland
  • +1 more
Apr 1, 2014